Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial
- PMID: 27157575
- DOI: 10.3168/jds.2015-10743
Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial
Abstract
We conducted a randomized double-blind, placebo-controlled multicentric study to investigate the influence of a synbiotic fermented milk on the fecal microbiota composition of 30 adults with irritable bowel syndrome (IBS). The synbiotic product contained Lactobacillus acidophilus La-5, Bifidobacterium animalis ssp. lactis BB-12, Streptococcus thermophilus, and dietary fiber (90% inulin, 10% oligofructose), and a heat-treated fermented milk without probiotic bacteria or dietary fiber served as placebo. Stool samples were collected after a run-in period, a 4-wk consumption period, and a 1-wk follow-up period, and were subjected to real-time PCR and 16S rDNA profiling by next-generation sequencing. After 4wk of synbiotic (11 subjects) or placebo (19 subjects) consumption, a greater increase in DNA specific for L. acidophilus La-5 and Bifidobacterium animalis ssp. lactis was detected in the feces of the synbiotic group compared with the placebo group by quantitative real-time PCR. After 1wk of follow-up, the content of L. acidophilus La-5 and B. animalis ssp. lactis decreased to levels close to initial levels. No significant changes with time or differences between the groups were observed for Lactobacillus, Enterobacteriaceae, Bifidobacterium, or all bacteria. The presence of viable BB-12- and La-5-like bacteria in the feces resulting from the intake of synbiotic product was confirmed by random amplification of polymorphic DNA (RAPD)-PCR. At the end of consumption period, the feces of all subjects assigned to the synbiotic group contained viable bacteria with a BB-12-like RAPD profile, and after 1wk of follow-up, BB-12-like bacteria remained in the feces of 87.5% of these subjects. The presence of La-5-like colonies was observed less frequently (37.5 and 25% of subjects, respectively). Next-generation sequencing of 16S rDNA amplicons revealed that only the percentage of sequences assigned to Strep. thermophilus was temporarily increased in both groups, whereas the global profile of the fecal microbiota of patients was not altered by consumption of the synbiotic or placebo. In conclusion, daily consumption of a synbiotic fermented milk had a short-term effect on the amount and proportion of La-5-like strains and B. animalis ssp. lactis in the fecal microbiome of IBS patients. Furthermore, both synbiotic and placebo products caused a temporary increase in fecal Strep. thermophilus.
Keywords: irritable bowel syndrome; metataxonomics; real-time PCR; synbiotic fermented milk.
Copyright © 2016 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. Nutrients. 2020. PMID: 32635661 Free PMC article. Clinical Trial.
-
Breastfeeding-associated microbiota in human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and Bifidobacterium animalis ssp. lactis Bb-12.J Dairy Sci. 2018 Feb;101(2):889-899. doi: 10.3168/jds.2017-13411. Epub 2017 Dec 14. J Dairy Sci. 2018. PMID: 29248229
-
Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.Dig Liver Dis. 2017 Apr;49(4):331-337. doi: 10.1016/j.dld.2017.01.142. Epub 2017 Jan 21. Dig Liver Dis. 2017. PMID: 28179092 Review.
-
THE EFFECT OF PROBIOTIC FERMENTED MILK THAT INCLUDES BIFIDOBACTERIUM LACTIS CNCM I-2494 ON THE REDUCTION OF GASTROINTESTINAL DISCOMFORT AND SYMPTOMS IN ADULTS: A NARRATIVE REVIEW.Nutr Hosp. 2015 Aug 1;32(2):501-9. doi: 10.3305/nh.2015.32.2.9232. Nutr Hosp. 2015. PMID: 26268077 Review.
-
Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.Int J Food Microbiol. 2011 Sep 1;149(1):50-7. doi: 10.1016/j.ijfoodmicro.2010.12.026. Epub 2011 Jan 15. Int J Food Microbiol. 2011. PMID: 21296446 Clinical Trial.
Cited by
-
Fermented foods, their microbiome and its potential in boosting human health.Microb Biotechnol. 2024 Feb;17(2):e14428. doi: 10.1111/1751-7915.14428. Microb Biotechnol. 2024. PMID: 38393607 Free PMC article. Review.
-
Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook.Probiotics Antimicrob Proteins. 2023 Nov 18. doi: 10.1007/s12602-023-10189-w. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37979040
-
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.Intest Res. 2024 Jan;22(1):15-43. doi: 10.5217/ir.2023.00080. Epub 2023 Nov 8. Intest Res. 2024. PMID: 37935653 Free PMC article. Review.
-
Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications.Microorganisms. 2023 Sep 22;11(10):2369. doi: 10.3390/microorganisms11102369. Microorganisms. 2023. PMID: 37894027 Free PMC article. Review.
-
Role of Diet-Microbiome Interaction in Gastrointestinal Disorders and Strategies to Modulate Them with Microbiome-Targeted Therapies.Annu Rev Nutr. 2023 Aug 21;43:355-383. doi: 10.1146/annurev-nutr-061121-094908. Epub 2023 May 28. Annu Rev Nutr. 2023. PMID: 37380178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical